AvePoint (AVPT) Exec Chair sells 41,679 & 18,321 shares

AvePoint, Inc. (AVPT) insider filing shows Executive Chairman and Director reported open‑market sales of common stock on two dates.

Rhea-AI Filing Summary

AvePoint, Inc. (AVPT) insider filing shows Executive Chairman and Director reported open‑market sales of common stock on two dates. On 11/03/2025, 41,679 shares were sold at $13.96 per share. On 11/04/2025, 18,321 shares were sold at $13.80 per share.

The transactions were made under a Rule 10b5-1 trading plan adopted on June 22, 2025. Following these sales, the reporting person beneficially owned 15,040,668 shares indirectly, held by various trusts and LLCs for which he is affiliated or acts as trustee.

Insider Trade Summary

Net Seller: 60,000 shares

Net Sell 2 txns

Insider Gong Xunkai

Role Executive Chairman

Sold 60,000 shs ($835K)

Type	Security	Shares	Price	Value
Sale	Common Stock	18,321	$13.80	$253K
Sale	Common Stock	41,679	$13.96	$582K

Holdings After Transaction: Common Stock — 15,040,668 shares (Indirect, Held by trusts and LLCs)

Footnotes (2)

1. F1. The sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 22, 2025.
2. F2. Includes (i) 3,965,953 shares held by Mr. Gong's affiliate Giocoso Holdings LLC, (ii) 459,929 shares held by Mr. Gong's affiliate Cadenza Holdings LLC, (iii) 170,465 shares held by Mr. Gong's affiliate Vivace Holdings LLC, each of which Mr. Gong may be deemed to beneficially own, (iv) 2,011,112 shares held by The Purple Harbor Trust, for which Mr. Gong is the trustee, (v) 2,011,112 shares held by The Purple Cove Trust, for which Mr. Gong is the trustee, and (vi) 6,422,097 shares held by G Sonata Trust, for which Mr. Gong is a trustee. The Reporting Person disclaims beneficial ownership with respect to the shares held by each trust and LLC, except to the extent his pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who reported the insider transactions for AVPT?

AvePoint’s Executive Chairman and Director reported the transactions, filing as a single reporting person.

When did the AVPT insider sales occur and at what prices?

On 11/03/2025 at $13.96 for 41,679 shares, and on 11/04/2025 at $13.80 for 18,321 shares.

How many AVPT shares does the insider own after these transactions?

After the reported sales, the filing lists 15,040,668 shares beneficially owned indirectly.

Was a Rule 10b5-1 plan used for these AVPT transactions?

Yes. The sales were effected under a Rule 10b5-1 plan adopted on June 22, 2025.

What is the insider’s relationship to AvePoint (AVPT)?

He is a Director and Officer, serving as Executive Chairman.

Are the AVPT shares held directly or indirectly?

They are held indirectly by trusts and LLCs, including Giocoso, Cadenza, Vivace LLCs and certain trusts where he serves as trustee.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/05/2025 - 09:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gong Xunkai

(Last) (First) (Middle)

C/O AVEPOINT, INC.

525 WASHINGTON BOULEVARD, SUITE 1400

(Street)

JERSEY CITY NJ 07310

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AvePoint, Inc. [ AVPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/03/2025		S		41,679(1)	D	$13.96	15,058,989	I	Held by trusts and LLCs
Common Stock	11/04/2025		S		18,321(1)	D	$13.8	15,040,668(2)	I	Held by trusts and LLCs

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 22, 2025.

2. Includes (i) 3,965,953 shares held by Mr. Gong's affiliate Giocoso Holdings LLC, (ii) 459,929 shares held by Mr. Gong's affiliate Cadenza Holdings LLC, (iii) 170,465 shares held by Mr. Gong's affiliate Vivace Holdings LLC, each of which Mr. Gong may be deemed to beneficially own, (iv) 2,011,112 shares held by The Purple Harbor Trust, for which Mr. Gong is the trustee, (v) 2,011,112 shares held by The Purple Cove Trust, for which Mr. Gong is the trustee, and (vi) 6,422,097 shares held by G Sonata Trust, for which Mr. Gong is a trustee. The Reporting Person disclaims beneficial ownership with respect to the shares held by each trust and LLC, except to the extent his pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.

	/s/ Brian Michael Brown, Attorney-in-Fact	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.